Radnor Capital Management LLC lessened its stake in Colgate-Palmolive (NYSE:CL) by 2.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 24,350 shares of the company’s stock after selling 500 shares during the quarter. Radnor Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,745,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of CL. Dimensional Fund Advisors LP boosted its position in Colgate-Palmolive by 3.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,737,377 shares of the company’s stock worth $103,412,000 after acquiring an additional 57,606 shares during the period. Geode Capital Management LLC boosted its position in Colgate-Palmolive by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after acquiring an additional 768,550 shares during the period. B. Riley Wealth Management Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $241,000. Psagot Investment House Ltd. boosted its position in Colgate-Palmolive by 38.9% during the 4th quarter. Psagot Investment House Ltd. now owns 4,073 shares of the company’s stock worth $242,000 after acquiring an additional 1,140 shares during the period. Finally, PFG Advisors acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $288,000. 75.61% of the stock is currently owned by institutional investors.

In other Colgate-Palmolive news, SVP John J. Huston sold 473 shares of the firm’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $72.93, for a total value of $34,495.89. Following the sale, the senior vice president now owns 59,668 shares of the company’s stock, valued at approximately $4,351,587.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ian M. Cook sold 19,500 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $74.19, for a total value of $1,446,705.00. Following the sale, the insider now directly owns 1,127,542 shares in the company, valued at approximately $83,652,340.98. The disclosure for this sale can be found here. Insiders sold a total of 362,184 shares of company stock worth $25,909,426 in the last ninety days. Insiders own 1.14% of the company’s stock.

CL has been the subject of a number of research reports. Bank of America set a $80.00 price objective on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Friday, July 12th. Zacks Investment Research lowered Home Bancshares from a “hold” rating to a “sell” rating in a research report on Friday, June 7th. Jefferies Financial Group restated a “buy” rating and set a GBX 265 ($3.46) price objective on shares of WM Morrison Supermarkets in a research report on Monday, April 29th. Morgan Stanley set a $70.00 price target on Edison International and gave the stock a “hold” rating in a research note on Monday, July 15th. Finally, JPMorgan Chase & Co. set a €118.00 ($137.21) price target on Deutsche Boerse and gave the stock a “neutral” rating in a research note on Monday, April 29th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $71.88.

Shares of CL traded up $1.76 during midday trading on Friday, reaching $73.69. 4,036,168 shares of the stock were exchanged, compared to its average volume of 3,009,639. The firm has a market cap of $63.26 billion, a P/E ratio of 24.81, a price-to-earnings-growth ratio of 4.70 and a beta of 0.78. The business has a 50 day simple moving average of $73.15. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.74 and a current ratio of 1.07. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $74.67.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.72. The firm had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.88 billion. Colgate-Palmolive had a negative return on equity of 3,730.37% and a net margin of 15.08%. The company’s revenue was down .5% on a year-over-year basis. During the same quarter last year, the firm posted $0.77 EPS. As a group, sell-side analysts predict that Colgate-Palmolive will post 2.84 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Thursday, July 18th will be issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date is Wednesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.91%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: Penny Stocks

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.